e8vk
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): December 3, 2009
ALKERMES, INC.
(Exact Name of Registrant as Specified in its Charter)
| |
|
|
|
|
| PENNSYLVANIA
|
|
1-14131
|
|
23-2472830 |
| (State or Other Jurisdiction of
|
|
(Commission
|
|
(I.R.S. Employer |
| Incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
| 88 Sidney Street |
|
|
| Cambridge, Massachusetts
|
|
02139 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (617) 494-0171
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Item 8.01 Other Events
On
December 3, 2009, Alkermes, Inc. (“Alkermes”) entered into an agreement with Acceleron Pharma,
Inc. (“Acceleron”) to license a proprietary long-acting Fc fusion technology platform, as described
in the attached press release. On execution of the agreement,
Alkermes made an upfront payment
of $2 million and an equity investment in Acceleron of $8 million. Alkermes will record the $2
million upfront payment as a research and development expense during the quarter ended December 31,
2009 and will record the $8 million as an investment on the
balance sheet. Richard Pops, the Chairman, President and Chief Executive Officer of Alkermes, is also a Director of Acceleron.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| |
|
|
| Exhibit |
|
|
| No. |
|
Description |
99.1
|
|
Press Release dated December 3, 2009 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
ALKERMES, INC.
|
|
| Date: December 3, 2009 |
By: |
/s/ James M. Frates
|
|
| |
|
James M. Frates |
|
| |
|
Senior Vice President, Chief
Financial Officer and Treasurer
(Principal Financial and Accounting
Officer) |
|
| |
EXHIBIT INDEX
| |
|
|
| Exhibit |
|
|
| No. |
|
Description |
99.1
|
|
Press Release dated December 3, 2009 |